Otros idiomas Kali, Inc.

Acciones

KALY

US4833801016

Diferido OTC Markets Otros sitios de cotización 17:12:39 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,000001 ^USD	-.--%		-.--%	-.--%

2019

Kali-Extracts, Inc. Proporciona una guía de ingresos para el cuarto trimestre de 2019

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand	19/05/21
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	12/05/21
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	06/05/21
Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	13/04/21
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	13/04/21
Alkame : PAO Group, Inc. Has Two CBD-Based Therapeutics In Play; Planned Launch For One In September Puts Catalyst In Play	07/04/21
Alkame : Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program	24/03/21
Puration Inc :.'s Stock Is In Bull Market Mode; Acquisitions And Strong Revenues Kick Off Big Start To 2021	03/02/21
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow	13/01/21
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021	12/01/21
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020	11/01/21
PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition	08/01/21
PAOG Expects to Report First Post Acquisition Revenue in Q4 2020	22/12/20
Kali : PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval	23/10/20
Kali : PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research	20/10/20
Kali : PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday	20/10/20
PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness	16/10/20
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND	01/10/20
PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction	30/09/20
PAOG Expands Cannabis Pharma Treatment Research	24/09/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Kali, Inc.

Acciones

KALY

US4833801016

Otros idiomas

Filtros